389: Hims' Super Bowl fallout, and the FDA reverses course
About this episode
The episode discusses the implications of Hims' Super Bowl ad, FDA regulatory changes, and updates on Moderna's vaccine and psychedelic medicine research.
Was Hims' Super Bowl ad the final straw for regulators? Is the bar being lowered for psychedelic medicines? And what's happening behind-the-scenes with Moderna and the Food and Drug Administration? We discuss all that on this week's episode of "The Readout LOUD." STAT's Katie Palmer joins Adam, Elaine, and Allison to discuss the Hims GLP-1 pill fallout. The hosts also discuss the latest on Moderna's influenza vaccine application and Compass Pathways' depression psychedelic data.
People in this episode
Hosts: Adam, Elaine, Allison
Guest: Katie Palmer
Topics covered
- Hims Super Bowl ad
- FDA regulations
- psychedelic medicines
- Moderna influenza vaccine
- depression treatment
Keywords
- Hims
- FDA
- Moderna
- psychedelic medicines
- influenza vaccine
- depression
- Super Bowl ad
Mentioned in this episode
Organizations: Hims, FDA, Moderna, Compass Pathways
More episodes of The Readout Loud
- 398: A CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts
- 397: A pancreatic cancer breakthrough, and new hope for an off-the-shelf CAR-T treatment
- 396: A new trick for old science, and biotech VCs' scrambled playbook
- 395: Biotech investors' plea to Trump, and a busy M&A week
- 394: Eli Lilly's deal man, Allogene's off-the-shelf CAR-T, and Merck's Terns buy
- 393: A conversation with the 'godfather' of biotech
Explore listener stats, chart rankings, contacts and more on the The Readout Loud podcast page.